₁₂Manlio Palumbo

Summary for 2004 [at-glance overview of Manlio Palumbo work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Manlio Palumbo. According to available data, in 2004 Manlio Palumbo published at least 12 articles. This work was completed in collaboration with several authors including Capranico, Giovanni and Moro, Stefano. Many other authors have collaborated with Manlio Palumbo as well. There is no information about the funding or the grants awarded to support this work.

Manlio Palumbo is a key opinion leader in the specific area of Intercalating Agents. This author's rank is 3 when compared to all other authors using the same keyword. Analysis of the article abstracts and the titles suggests that Manlio Palumbo professional interests are focused around "binol quinone methides", "interaction antiviral quinolone" and "region interaction antiviral". These might also be referred to as "topoisomerase ii", "drug activity" or "model anthracycline". Statistical analysis shows that Manlio Palumbo's writing is likely to contains terms "dna", "activity", "drug", "ii", "drugs" and "group".

The majority of Manlio Palumbo articles are affiliated with Department of Pharmaceutical Sciences, University of Padova, Via Marzolo, 5, 35131 Padova, Italy and Dipartimento di Chimica Organica, Università di Pavia, Via le Taramelli 10, 27100 Pavia, Italy. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Manlio Palumbo]

Do you know Manlio Palumbo who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Manlio Palumbo]

₄₄Palumbo, M

Year 2004 Charts [Manlio Palumbo frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Manlio Palumbo publication and funding history for the range of years]

Emails (3) [email addresses extracted from Manlio Palumbo affiliations]

hidden to prevent spam, click here to reveal

Manlio Palumbo Coauthors (31) [all coauthors with the number of joint publications]

4

3

3

3

2

2

2

2

2

2

2

1

1

₁₂Pannecouque, Christophe

1

1

1

1

1

₂Brocca-Cofano, Egidio

1

1

1

1

1

1

1

₁Del Vecchio, Claudia

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (7) [condensed summary of the Manlio Palumbo affiliations, the leading number and the color conveys importance]

₆Department of Pharmaceutical Sciences, University of Padova, Via Marzolo, 5, 35131 Padova, Italy.
₁Dipartimento di Chimica Organica, Università di Pavia, Via le Taramelli 10, 27100 Pavia, Italy.
₁Dipartimento di Chimica e Tecnologia del Farmaco, Università di Perugia, Via del Liceo 1, 06123 Perugia, Italy.
₁Department of Biochemistry G. Moruzzi, Alma Mater Studiorum University of Bologna, via Irnerio 48, 40126 Bologna, Italy.
₁Department of Pharmaceutical Science, University of Padova, Italy.
₁Department of Pharmaceutical Sciences, University of Padua, 35131 Padua, Italy.
₁Dipartimento di Scienze Chimiche e Istituto CNR Tecnologia delle Membrane-Sezione di Padova, Università di Padova, via Marzolo 1, I-35131 Padua, Italy.

Key Opinion Leader In [Manlio Palumbo is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₃Intercalating Agents | ₄₂Drug Design | ₁₅₇DNA | ₃₁₈Enzyme Inhibitors | ₃₆₆Neoplasms | ₄₅₆Antineoplastic Agents | ₅₀₃Models, Molecular

Keywords (32) [keywords assigned to Manlio Palumbo articles by PubMed, the leading number and the color conveys importance]

₆Humans | ₄Models, Molecular | ₄DNA | ₃Neoplasms | ₃Drug Design | ₃Antineoplastic Agents | ₃Intercalating Agents | ₃Animals | ₃Enzyme Inhibitors | ₂Diterpenes | ₂Anti-HIV Agents | ₂Plasmids | ₂Anthraquinones | ₂DNA Damage | ₂Binding Sites | ₂Alkylating Agents | ₂Molecular Conformation | ₂DNA Topoisomerases, Type II | ₂Anthracyclines | ₂HIV-1 | ₂Mutation | ₂Quinolones | ₁Cyclohexanes | ₁Organometallic Compounds | ₁Cytosine | ₁Tumor Cells, Cultured | ₁Specimen Handling | ₁DNA Topoisomerases, Type I | ₁Yeasts | ₁Protein Structure, Tertiary | ₁Aza Compounds | ₁Gene Products, tat

Manlio Palumbo Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Manlio Palumbo might be a good expert witness on these terms]

₃₀dna | ₁₇activity | ₁₅drug | ₁₄ii | ₁₄drugs | ₁₁group | ₁₀topoisomerase | ₁₀derivatives | ₉antiviral | ₈derivative | ₈agents | ₇anticancer | ₆epoxide | ₆properties | ₆inhibition | ₆results | ₆antitumor | ₆clerocidin | ₆top2 | ₅potent | ₅action | ₅effects | ₅shown | ₅structural | ₅interaction | ₄virus | ₄wm5 | ₄can | ₄system | ₄human | ₄quinolone | ₄ring
₉topoisomerase ii | ₄drug activity | ₃model anthracycline | ₃anticancer agents | ₃potent anti-hiv | ₂region interaction | ₂biophysical biochemical | ₂immunodeficiency virus | ₂cap-like domain | ₂interaction antiviral | ₂virus type | ₂systems drug | ₂modifications 6-aminoquinolones | ₂potential aza-bioisosterism | ₂spiro system | ₂type tat-trans-activation-responsive | ₂towards future | ₂properties quinolone-based | ₂effects common | ₂activity case | ₂common buffer | ₂9-aza regioisomers | ₂results provide | ₂reversible irreversible | ₂anti-hiv activity | ₂lead wm5 | ₂agents towards | ₂replication cycle | ₂clinical trials | ₂antiviral quinolone | ₂antitumor potential | ₂aza-bioisosterism anthracenedione-based
₃binol quinone methides | ₂interaction antiviral quinolone | ₂region interaction antiviral | ₂virus type tat-trans-activation-responsive | ₂studies 9-aza regioisomers | ₂aza-anthrapyrazoles biophysical biochemical | ₂biophysical biochemical studies | ₂effects common buffer | ₂antiviral properties quinolone-based | ₂structure modifications 6-aminoquinolones | ₂buffer systems drug | ₂properties quinolone-based drugs | ₂type tat-trans-activation-responsive region | ₂systems drug activity | ₂human immunodeficiency virus | ₂antitumor aza-anthrapyrazoles biophysical | ₂drug activity case | ₂anticancer agents towards | ₂common buffer systems | ₂antiviral quinolone derivative | ₂activity case clerocidin | ₂inhibition human immunodeficiency | ₂immunodeficiency virus type | ₂antitumor potential aza-bioisosterism | ₂6-aminoquinolones potent anti-hiv | ₂modifications 6-aminoquinolones potent | ₂biochemical studies 9-aza | ₂agents towards future | ₂potent anti-hiv activity | ₂tat-trans-activation-responsive region interaction | ₂aza-bioisosterism anthracenedione-based drugs | ₂potential aza-bioisosterism anthracenedione-based

Reader's Comments (0) [comments posted by readers of Manlio Palumbo profile]